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Type 3 secretion system
Toxins
a  b  s  t  r  a  c  t
Escherichia  coli  was  described  in  1885  by a German  pediatrician,  Theodor  Escherich,  in
the faeces  of  a  child  suffering  diarrhoea.  In 1893,  a Danish  veterinarian  postulated  that
the E.  coli  species  comprises  different  strains,  some  being  pathogens,  others  not.  Today
the E. coli  species  is  subdivided  into  several  pathogenic  strains  causing  different  intestinal,
urinary  tract  or internal  infections  and  pathologies,  in animal  species  and  in humans.  Since
this congress  topic  is the interaction  between  E.  coli and  the mucosal  immune  system,  the
purpose of  this  manuscript  is to  present  different  classes  of adhesins  (ﬁmbrial  adhesins,
aﬁmbrial  adhesins  and  outer  membrane  proteins),  the  type  3 secretion  system,  and  some
toxins  (oligopeptide,  AB,  and  RTX  pore-forming  toxins)  produced  by E.  coli,  that  can  directly
interact  with  the  epithelial  cells  of  the  intestinal,  respiratory  and  urinary  tracts.
© 2012 Elsevier B.V. All rights reserved.
1. Pathogenic Escherichia coli
Escherichia coli is a Gram-negative, rod-shaped bac-
terium belonging to the family Enterobacteriaceae that
was described in 1885 by a German pediatrician, Theodor
Escherich (1857–1911) in the faeces of a child suffering
diarrhoea (Escherich, 1885). While many strains occur as
commensal members of the microbiota in the intestinal
tract of animals and humans, some strains are, however,
important pathogens that cause a wide spectrum of
diseases, ranging from self-limiting to life-threatening
intestinal and extra-intestinal illnesses (Sussman, 1997;
Wray and Woodward, 1997; Kaper et al., 2004; Nataro
et al., 2011). This was a puzzling observation at the time,
because according to the Koch’s postulates (Koch, 1884),
one bacterial species was either pathogen or not. In 1893,
a Danish veterinarian postulated that the E. coli species
comprises different strains, some being pathogens, others
not (Jensen, 1893). Not only his assertion proved true but
also E. coli is today subdivided into several pathogenic
strains causing different intestinal, urinary tract or internal
∗ Tel.: +32 4 3669522; fax: +32 4 3664261.
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infections and pathologies, in all animal species and in
humans. Those pathogenic E. coli serotypes were therefore
named by the clinical syndrome they can cause (Table 1 ):
diarrhoeagenic E. coli (DEC), uropathogenic E. coli (UPEC),
septicaemic E. coli (SePEC), neonatal meningitis-associated
E. coli (NMEC), etc.; or sometimes according to the target
host: avian pathogenic E. coli (APEC) (Mainil, 2003a).
The question soon changed to how identifying in vitro
the pathogenic strains of E. coli. The ﬁrst answer came
from the serotyping system developed by Kauffmann in
the 1940s, i.e. the identiﬁcation of somatic (O antigen),
capsular (K antigen) and ﬂagellar (H antigen) surface anti-
gens (Kauffmann, 1947). Some serotypes are indeed more
frequently than others associated with speciﬁc clinical syn-
dromes (Sojka, 1965; Orskov and Orskov, 1992; Lior, 1994).
Fortunately from the late 1960s onwards, several spe-
ciﬁc properties that differentiate the pathogenic strains
from each other and from non-pathogenic strains were
unravelled. It therefore became possible to name the
different classes of pathogenic E. coli on the basis of
their speciﬁc properties instead of the clinical syndrome
they can produce. Focusing on diarrhoeagenic E. coli,
three classes were so deﬁned in humans in the 1970s
(World Health Organization, 1980) (Table 1): enterotox-
igenic E. coli (ETEC) producing (entero)toxins causing
0165-2427/$ – see front matter ©  2012 Elsevier B.V. All rights reserved.
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hypersecretion of electrolytes and water by enterocytes of
domestic animals and humans, enteroinvasive E. coli (EIEC)
invading the enterocytes of humans and primates, and
enteropathogenic E. coli belonging to speciﬁc serotypes,
pathogenic for humans, but whose virulence properties
were still unknown at the time.
More properties of DEC were progressively discovered
in the 1980s and 1990s and more classes were named on
the basis of adherence and/or toxic properties (Table 1):
attaching-effacing E. coli (AEEC), diffusely adherent E. coli
(DAEC), enteroaggregative E. coli (EAEC), Shiga/Vero-
toxigenic E. coli (VTEC), necrotoxigenic E. coli (NTEC),
diarrhoea-associated haemolytic E. coli (DHEC), and still
others. But some names still referred to history, like
enteropathogenic E. coli (EPEC) sensu stricto,  and others to
clinical syndromes, like enterohaemorrhagic E. coli (EHEC)
(Table 1). Therefore some names are today obsolete,
while some strains received different names based on the
clinical syndromes, the host target species and/or their
virulence properties, respectively. Several review articles
on the E. coli pathotypes in humans and animals have
been published more or less recently (Nataro and Kaper,
1998; De Rycke et al., 1999; Dho-Moulin and Fairbrother,
1999; Nagy and Fekete, 1999; Kaper et al., 2004; Mainil
and Daube, 2005; Gyles and Fairbrother, 2010).
Since the topic of the ECMIS congress is the interaction
between E. coli and the mucosal immune system, the pur-
pose of this manuscript is to give an overview of the most
important virulence-associated properties of E. coli that
can directly interact with the epithelial cells, i.e. adherence
factors and “exotoxins”. The adherence to the epithelial
cells is mediated by surface structures or molecules, like
the ﬁmbrial adhesins, the aﬁmbrial adhesins and/or outer
membrane proteins (OMPs). The “exotoxins” (so-called
although not all are actually excreted in the extracellular
environment) are proteins that can target either the cell
skeleton (type 3-secreted effectors), or the cell metabolism
(intracellular AB toxins with enzymatic activity; oligopep-
tide toxins activating a metabolic cascade after ﬁxation on
the cell cytoplasmic membrane), or the cell cytoplasmic
membrane (enzymatic and pore-forming cytolysins).
2. The adhesins and colonization factors
At least three different general classes of E. coli adhesins
can be deﬁned: different appendices like ﬁmbriae, ﬁbril-
lae and curli, the aﬁmbrial family (Afa), and speciﬁc outer
membrane proteins (OMPs) like the intimin (Kaper et al.,
2004; Mainil, 2005a).
2.1. The appendices
Duguid et al. (1955) described electron microscope
visible appendices responsible for the agglutination of
erythrocytes by some E. coli strains, that they named
“ﬁmbriae” (=thread, fringe or ﬁbre in Latin). At the
beginning those appendices also received the name of
“pili”, but today it is advised to give the latter name
only the appendices involved in plasmid conjugation. In
addition, it soon became obvious that several classes of
ﬁmbrial appendices existed and several classiﬁcations
Author's personal copy
J. Mainil / Veterinary Immunology and Immunopathology 152 (2013) 2– 12 5
have been proposed, none of them being fully satisfying.
Orskov and Orskov (1990) proposed four classes of
appendices on the basis of their ultra-structure: rigid,
thick (5–7 nm)  with a central hole, peritrichous appen-
dices or ﬁmbriae sensu stricto;  ﬂexible, thin (2–3 nm)
with no axial hole, peritrichous appendices or ﬁbrillae
(=thin, small ﬁbres in Latin); ﬂexible, moderately thick
(4–6 nm), bundle- or rope-forming, polar appendices or
type 4 ﬁmbriae (this name is a heritage from previous
classiﬁcations); and highly ﬂexible, very thin, aggregated
appendices or curli (=curve, spiral, loop in Latin).
Those appendices are shafts protruding from the bacte-
rial cell surface and comprise different proteins (Wu and
Fives-Taylor, 2001; Bann et al., 2002; Clarke et al., 2003;
Mainil, 2003a, 2005a; Barnhart and Chapman, 2006). Struc-
turally the shaft is made of several hundreds copies of a pro-
tein, whose generic name is “major subunit” of a molecular
weight between 15 and 20 kDa, but that received different
other names according to the actual appendix (pilin, ﬁm-
brin, or curlin f.i.). Several other proteins, present in one or
a very few copy number and called “minor proteins”, are
present either at the basis or at the top of the shaft or inter-
calated between the “major subunits”. The minor subunits
present at the basis anchor the shaft within the outer mem-
brane of E. coli. The adherence property of the appendices,
i.e. the actual interaction between the bacterial adhesin
and the eukaryotic receptor, can be mediated (i) by a spe-
ciﬁc minor subunit protein present in one copy at the top
of the shaft or in several copies intercalated between the
major subunit proteins; or (ii) by a domain of the major sub-
unit protein itself, either only the copy present at the top
of the shaft or several copies along the shaft. Appendices
involved in adherence to host cells and tissues are grouped
into families according to their receptor primary speci-
ﬁcity (=macroevolution), usually the carbohydrate moiety
of glycoproteins or glycolipids, but also peptide sequences.
Members within each family can also have subtle differ-
ences in the actual identity of their oligosaccharide or
oligopeptide receptors sometimes leading to different tis-
sue and/or host speciﬁcity (=microevolution).
E. coli ﬁmbriae and ﬁbrillae adhesins were at ﬁrst
described on enterotoxigenic E. coli (ETEC) from pigs,
calves and then humans (Nataro and Kaper, 1998;
Nagy and Fekete, 1999; Kaper et al., 2004; Gyles and
Fairbrother, 2010). They were thereafter also described
on uropathogenic (UPEC), septicaemic (SePEC), avian
pathogenic (APEC) and necrotoxigenic (NTEC) E. coli
(Table 1) (Donnenberg and Welch, 1996; De Rycke et al.,
1999; Dho-Moulin and Fairbrother, 1999; Mainil et al.,
1999; Wu  and Fives-Taylor, 2001; Stordeur et al., 2002;
Mainil, 2003a).  They received different names at the time
of their description, but today most are named by the letter
F followed by numbers (Orskov and Orskov, 1990): F2
(Colonization Factor Antigen (CFA) 1), F3 (CFA2), F4 (K88
antigen), F5 (K99 antigen), F6 (987 strain pili), F18 (F107,
8818, 2134 pili), F41 (B41 strain ﬁmbriae) of ETEC; F7–F16
(Pap/Prs ﬁmbriae) of UPEC, SePEC, APEC, NTEC; F1 (type 1)
causing mannose-sensitive haemagglutination, produced
by almost all strains of E. coli and probably involved in
the early steps of the colonization of the air sacs by APEC;
F17 (FY, Att25, Att111, Vir adhesin) produced by different
ETEC, SePEC, UPEC, APEC, and NTEC. The genes coding for
the different ﬁmbriae and ﬁbrillae can be plasmid-located,
especially in ETEC or chromosome-located sometimes on
speciﬁc pathogenicity islands, like in UPEC (Johnson, 1991;
Nataro and Kaper, 1998; Nagy and Fekete, 1999; Mainil,
2003a; Johnson, 2003; Kaper et al., 2004; Mainil, 2005a;
Nataro, 2005; Rasko et al., 2008; Gyles and Fairbrother,
2010).
The E. coli best known type 4 ﬁmbriae, or
Bundle-Forming Pili (BFP) are produced by typical
enteropathogenic E. coli (tEPEC) (Table 1), a sub-class of
human EPEC (Wu and Fives-Taylor, 2001; Clarke et al.,
2003; Bardiau et al., 2010). Non BFP-producing EPEC
from humans and animals are called atypical (a) EPEC
(Nataro and Kaper, 1998; Trabulsi et al., 2002; Kaper et al.,
2004; Hernandes et al., 2009). The BFP, that are encoded
by plasmid-located genes, were at ﬁrst thought to be
involved in adherence to the human enterocytes, but are
today believed to help bacteria to stick together forming
micro-colonies at the surface of the host cells, also called
“Localized Adherence” (LA) pattern (Scaletsky et al., 1984;
Nataro and Kaper, 1998; Kaper et al., 2004). Other type
4-like ﬁmbriae, the Longus Pilus, are produced by some
human ETEC strains that, in addition to promoting intesti-
nal colonization, may  also play a role in the protection of
the bacteria from antimicrobial agents (Giron et al., 1997;
Clavijo et al., 2010).
Curli that are encoded by chromosome-located genes,
are produced by different pathogenic E. coli strains, more
especially SePEC and some EHEC. Curli may  be involved in
the adherence of SePEC to the mucosal extracellular matrix
after fragilization of the epithelium and in the formation
of bioﬁlm on organic (not only animals, but also plants)
and non-organic surfaces by O157:H7 EHEC and other
pathogenic strains. But more studies are needed, especially
in vivo to more precisely understand their role in E. coli
pathogenicity (Wu and Fives-Taylor, 2001; Barnhart and
Chapman, 2006; Goulter et al., 2009; Saldana et al., 2011).
All ﬁmbriae are good immunogens since the major
subunit is a 15–25 kDa protein and is present in several
hundreds of copies. Vaccination of the pregnant dams
to protect newborn calves, lambs and piglets against
infections by ETEC via colostral antibodies is actually based
on vaccines containing (semi-)puriﬁed ﬁmbriae (F4, F5, F6,
F17 and/or F41) (Nagy and Fekete, 1999; Radostits et al.,
2007). But no other vaccine with proved value is currently
available to our knowledge.
2.2. The aﬁmbrial family of adhesins
Duguid et al. (1955) had already observed that several
appendix non-producing E. coli strains could also cause the
agglutination of erythrocytes. Those haemagglutinins actu-
ally form a family of genetically related different adhesins,
the AFimbrial adhesin (Afa) family regrouping Afa, Dr, M,
Nfa, F1845 and AAF variants. Aﬁmbrial adhesins of the Afa
family are encoded by plasmid- or chromosome-located
genes, according to the variant, but also sometimes within
one variant (Law and Chart, 1998; Le Bouguénec and Bertin,
1999; Mainil, 2003a, 2005a; Servin, 2005; Harrington et al.,
2006). While some members of the family are true aﬁmbrial
Author's personal copy
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adhesins (Afa, Dr, M),  others form small ﬁbrillae (F1845,
AAF), and still others capsule-like structures surrounding
the bacterial cell (Nfa). The structure of the true aﬁmbrial
adhesins can be compared to truncated ﬁmbriae with no
major subunit, but only the minor subunits of the basis and
the adhesin subunit. One of the minor-like subunits is an
invasin participating to the invasion of cells in cultures (Le
Bouguénec and Bertin, 1999; Servin, 2005).
With the exception of AAF-positive strains, aﬁmbrial
adhesin-producing E. coli display a diffuse adherence
(DAEC) pattern on cells in cultures, Hep-II, HeLa, or
MDCK, according to the variant (Scaletsky et al., 1984; Le
Bouguénec and Bertin, 1999; Servin, 2005). The receptor
for most aﬁmbrial adhesins produced by human strains
is the protein moiety of the Decay-Accelerating factor
(DAF), a glycoprotein distributed on human haemopoeitic
endothelial, intestinal and urinary cells. On the other hand
the only so far recognized aﬁmbrial adhesin produced by
pathogenic E. coli from animals (Afa-VIII, related to the M
aﬁmbrial adhesin of some human UPEC) does not recog-
nize DAF as a receptor and does not adhere to Hep-II or
HeLa cells (Lalioui et al., 1999; Le Bouguénec and Bertin,
1999; Mainil, 2003a, 2005a; Servin, 2005). Other receptors
for Afa and Dr adhesins of human DAEC are type IV collagen
and CEACAMs (CarcinoEmbryonic Antigens-related Cell-
Adhesion Molecules) (Servin, 2005). The DAEC strains are
associated with urinary tract (UPEC), intestinal tract (DEC)
and invasive (SePEC) infections in humans, different other
mammalian species and poultry (APEC) (Table 1) (Mainil
et al., 1997, 1999, 2001; Le Bouguénec and Bertin, 1999;
Gérardin et al., 2000; Stordeur et al., 2002; Servin, 2005).
AAF adhesins are small ﬁbrillae (Harrington et al., 2006)
and AAF-positive E. coli strains do not display the DA pat-
tern, but the aggregative (or ‘stacked-brick’) adherence
pattern on Hep-II and HeLa cells (Levine, 1987; Flores and
Okhuysen, 2009). Those strains were named enteroadher-
ent E. coli (EAEC), but are today named enteroaggregative E.
coli (EAggEC) (Table 1) (Levine, 1987; Law and Chart, 1998).
AAF ﬁbrillae promote auto-agglutination of EAggEC and
also mediate bacterial adherence to extracellular matrix
proteins, more precisely ﬁbronectin, laminin, and collagen
IV (Nataro, 2005; Harrington et al., 2006; Huang et al., 2006;
Weintraub, 2007; Farfan et al., 2008; Flores and Okhuysen,
2009). But the aggregative adherence pattern actually
encompasses both pathogenic and non-pathogenic E. coli
strains. Pathogenic EAggEC represent emerging speciﬁc
human pathogens responsible for acute or persistent diar-
rhoea in children and adults worldwide (Levine, 1987;
Huang et al., 2006; Weintraub, 2007; Flores and Okhuysen,
2009). In vivo pathogenic EAggEC not only adhere to entero-
cytes and to the extracellular intestinal matrix, but also
form mucoid bioﬁlms at the surface of the intestinal epithe-
lium of the terminal ileum and of the colon (Nataro, 2005;
Weintraub, 2007; Farfan et al., 2008). The recent outbreak
of haemorrhagic colitis and haemolytic–uremic syndrome
in Germany was caused by one EAggEC having acquired
the genes coding for a verotoxin (see Section 4) by hori-
zontal transfer by phage transduction (Piérard et al., 2012;
Bielaszewska et al., 2011; Scheutz et al., 2011). Such AAF-
positive E. coli strains have not been described in animals
yet.
2.3. Outer membrane proteins (OMPs)
Different speciﬁc OMPs of pathogenic E. coli strains
are also involved in bacteria–eukaryotic cell adherence,
bacteria–bacteria adherence and/or bioﬁlm formation
(Table 1): the plasmid-encoded Adhesin Involved in Dif-
fuse Adherence (AIDA) of human and porcine ETEC
and VTEC (Niewerth et al., 2001; Mainil et al., 2002;
Sherlock et al., 2004; Bardiau et al., 2010), the chromo-
some or plasmid-encoded Porcine Attaching-and-effacing-
Associated adhesin (Paa) of porcine EPEC and ETEC and
of human O157:H7 EHEC (An et al., 1999; Amezcua
et al., 2002; Leclerc et al., 2007; Hernandes et al., 2009;
Bardiau et al., 2010), the plasmid-encoded Shigatoxigenic
Autoagglutinating Adhesin (Saa) of human and bovine
VTEC (Jenkins et al., 2003; Bardiau et al., 2010), and the
chromosome-encoded intimin adhesin (Int) of human and
animal EPEC and EHEC (Clarke et al., 2003; Mainil, 2005a;
Hernandes et al., 2009), for instance.
The intimin adhesin is a 94 kDa OMP  encoded by a gene
(eae) located on a pathogenicity island named Locus of
Enterocyte Effacement (LEE) along with other genes coding
for the formation of the Attaching and Effacing (AE) lesion
produced by EPEC and EHEC (Nataro and Kaper, 1998;
Clarke et al., 2003; Mainil, 2005a; Hernandes et al., 2009).
Different types of intimin adhesins have been described
that differ in their amino-acid carboxy terminal sequence.
These intimins are designated by Greek letters and corre-
lated to the EHEC and EPEC serotypes (Oswald et al., 2000;
Schmidt, 2010). The other LEE-located genes code for a type
3 secretion system (T3SS) and for type 3-secreted effectors
into the eukaryotic cell (see Section 3).
One of the type 3-secreted effectors is the Tir (Translo-
cated Intimin Receptor) protein that can have different
functions after incorporation into the enterocyte cytoplas-
mic  membrane, including serving as a receptor for the
intimin adhesin. The Tir protein exhibits a hairpin confor-
mation with the extracellular loop binding to the intimin
and the amino- and carboxy-terminal domains projecting
into the host cells and interacting with the actin network
of the cytoskeleton to form the AE lesion. Different types
of Tir proteins have also been described. Since the interac-
tion between intimin and Tir is located in the 280 carboxy
terminal amino-acids of the intimin adhesin, the differ-
ent intimin types speciﬁcally interact with their cognate
Tir receptor (China et al., 1999; Hartland et al., 1999; Luo
et al., 2000; Karmali et al., 2010; Schmidt, 2010). Alterna-
tive host receptors for the intimin adhesin are 1 integrins
and nucleolin (Garmendia et al., 2005).
3. The type 3 secretion system (T3SS)
One important characteristic of EPEC and EHEC strains is
their ability to provoke the disappearance of the enterocyte
microvilli and to intimately attach to the nude cytoplasmic
membrane of the enterocyte (AE lesions). AE lesions are the
results of a profound disorganization of the actin ﬁlaments
of the eukaryotic cell skeleton and of their re-organization
beneath the intimately attached bacteria to form pedestals
(Nataro and Kaper, 1998; Clarke et al., 2003; Kaper et al.,
Author's personal copy
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2004; Garmendia et al., 2005; Mainil and Daube, 2005;
Moxley and Smith, 2010; Schmidt, 2010; Bolton, 2011).
A large bacterial chromosomal pathogenicity island, the
locus of enterocyte effacement (LEE), carries all (or almost
all according to the seropathotypes) genes necessary for
the formation of the AE lesions. They are grouped into sev-
eral functional gene clusters, the most important being:
the espA, B, D genes coding for the type 3 secretion sys-
tem (T3SS) structural proteins (or injectisome); the esc/sep
genes coding for the anchor structure of the injectisome
within the outer and inner bacterial membranes; the tir and
several other genes coding for the type 3-secreted effectors
into the eukaryotic cells; and the eae gene coding for the
intimin adhesin located within the bacterial outer mem-
brane (see Section 2.3) (Clarke et al., 2003; Garmendia et al.,
2005; Mainil and Daube, 2005; Moxley and Smith, 2010;
Schmidt, 2010; Bolton, 2011).
The injectisome is composed of polymerized EspA pro-
tein with the EspB and EspD proteins at the top forming
a pore within the eukaryotic cytoplasmic membrane. To
some extent the injectisome functions as one adhesin
connecting the bacteria to the eukaryotic cells, through
which the type 3-secreted effectors translocate into the
enterocytes (China and Goffaux, 1999; Clarke et al., 2003;
Garmendia et al., 2005; Schmidt, 2010).
4. The exotoxins
The ﬁrst toxins (оо = poison) were described at the
end of the 19th century: the diphtheria toxin in 1888 by
Roux and Yersin, the tetanus toxin in 1890 by Faber and
the botulinum toxin in 1898 by van Ermengen. Today sev-
eral classes of bacterial toxins are described according to
structural and functional criteria: (i) oligopeptide toxins
interfering indirectly with the eukaryotic cell metabolism
by activating an intracellular cascade after binding to
their receptor on the cytoplasmic membrane; (ii) AB tox-
ins directly interfering with the eukaryotic cell structure
or metabolism after receptor-mediated endocytosis; (iii)
enzymatic and RTX pore-forming cytolysins perturbing
the eukaryotic cell cytoplasmic membrane; (iv) type 3-
secreted effectors (see Section 3) (Mainil, 2003b, 2005b).
4.1. The oligopeptide toxins
Several bacterial species produce oligopeptide toxins,
like E. coli,  Vibrio cholerae, Yersinia enterocolitica, Klebsiella
pneumoniae, and Enterobacter aerogenes (Mainil, 2005b).
E. coli even produces different oligopeptide toxins, like the
heat-stable enterotoxins of enterotoxigenic strains (STaP,
STaH and STb) and the heat-stable enterotoxin of enteroag-
gregative strains (EAST1) (Smith and Halls, 1967; Burgess
et al., 1978; Moseley et al., 1983; Savarino et al., 1993). STaP
and STaH are 18 and 19 amino-acid peptides respectively
of a molecular weight of less than 2 kDa (Moseley et al.,
1983), whereas STb is a 48 amino-acid peptide of ca. 5 kDa
(Dubreuil, 2008) and EAST1 is a 38 amino-acid toxin of ca.
4 kDa (Savarino et al., 1993). Because of their low molecular
weight, no oligopeptide toxin is a good immunogen.
STaP is produced by animal (bovine, ovine, porcine and
canine) and human ETEC strains, while STaH is produced
only by human ETEC strains, STb by porcine ETEC strains,
and EAST1 by human EAggEC and by bovine, human and
porcine ETEC, EPEC, VTEC strains (Table 1) (Wasteson
et al., 1988; Mainil et al., 1998a; Nataro and Kaper, 1998;
Nagy and Fekete, 1999; Kaper et al., 2004; Nataro, 2005;
Weintraub, 2007; Gyles and Fairbrother, 2010). All STaP-,
STaH-, STb- and EAST1-encoding genes are plasmid-
located (Gyles et al., 1974; Mainil et al., 1992, 1998b;
Mainil, 2002; Nataro, 2005; Weintraub, 2007; Gyles and
Fairbrother, 2010). STaH, STaP, and probably EAST1 (based
on structural similarity), exert their toxicity via activation
of an intra-cellular cascade (Sears and Kaper, 1996; Kaper
et al., 2004; Gyles and Fairbrother, 2010), while STb seems
to act as a non-speciﬁc pore-forming toxin (Gonc¸ alves
et al., 2007; Dubreuil, 2008). If newborn calves, lambs,
piglets and babies in developing countries are sensitive to
the action of STaP and/or STaH that can also be involved
in traveller’s diarrhoea, the in vivo roles of STb and EAST1
are still controversial (Nataro and Kaper, 1998; Nagy and
Fekete, 1999; Kaper et al., 2004; Dubreuil, 2008; Gyles and
Fairbrother, 2010; Konno et al., 2011).
Both STaP and STaH are synthesized as a pre-protoxin of
72 amino acids that is secreted by a type 2 secretion system
(general or Sec-dependent secretion pathway) (China and
Goffaux, 1999) into the periplasmic space of the bacteria
after removal of the 18 amino-acid long signal sequence.
Further processing occurs in the periplasmic space or dur-
ing the crossing of the outer membrane to produce the
active 18 (STaP) or 19 (STaH) amino-acid toxins with three
disulﬁde bonds (Rasheed et al., 1990; Sears and Kaper,
1996). The receptor of both STa is a transmembrane gly-
coprotein with guanylate cyclase activity (guanylyl cyclase
C) of the intracytoplasmic domain, that is present at the
height of the microvilli of the enterocytes (Nataro and
Kaper, 1998; Nagy and Fekete, 1999; Kaper et al., 2004;
Gyles and Fairbrother, 2010). The intracellular levels of
cyclic guanosine monophosphate (cGMP) regulate several
cellular processes including the activity of ion pumps, like
the main ion channel of epithelial cells (the cystic ﬁbrosis
transmembrane conductance regulator: CTFR). The action
of either STa results in the stimulation of chloride and water
secretion and the inhibition of sodium absorption, leading
to watery diarrhoea.
4.2. The AB toxins
Some bacterial AB toxins (Mainil, 2005b)  are actually
composed of two  separate subunits, with one copy of the
A subunit and one to several copies of the B subunit. Other
AB toxins are actually single proteins composed of two
domains corresponding to the A and B subunits. The A
subunit/domain is the toxic component and the B sub-
unit(s)/domain binds the whole toxins to the receptors on
the eukaryotic cell membrane. After activation by enzy-
matic cleavage, the A subunit/domain can exert its toxic
(enzymatic) activity: interference with the cytoskeleton
integrity, the protein synthesis, the DNA metabolism, or
different secretion pathways.
As examples, two  types of AB E. coli toxins whose
interactions with eukaryotic cells are well understood
and whose role in vivo has been proved are going to
Author's personal copy
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be described: the heat-labile enterotoxin (LT) of human,
porcine and ruminant ETEC and the Vero/Shiga tox-
ins (VTx/Stx) of human, porcine and bovine EHEC and
VTEC.
4.2.1. The heat-labile enterotoxins
Besides the STa and STb oligopeptide enterotoxins (see
Section 4.1), porcine and human ETEC strains can also pro-
duce an A1B5 heat-labile enterotoxin or LT (Table 1) (Gyles
and Barnum, 1969; Honda et al., 1981). Porcine and human
LT (LTp and LTh) are both related to the cholera toxin
(CT) of Vibrio cholerae (Clements and Finkelstein, 1978) but
slightly differ antigenically from each other (Honda et al.,
1981). Genes coding for LTp and LTh are located on plas-
mids (Gyles et al., 1974; Mainil et al., 1998b; Nataro and
Kaper, 1998; Nagy and Fekete, 1999; Kaper et al., 2004;
Nataro, 2005; Weintraub, 2007; Gyles and Fairbrother,
2010).
LT are secreted by the type 2 secretion system (China
and Goffaux, 1999) involving the removal of the signal
sequences. After binding of the B subunits to their speciﬁc
receptors (the main receptor of LT and CT is ganglio-
side GM1) on the host cells, whole LT are internalized
by receptor-mediated endocytosis and begin a retrograde
transport in the endocytic vesicles to the endoplasmic
reticulum via the Golgi apparatus. There the A subunit
is enzymatically cleaved into a large A1 and a small
A2 fragments and the A1 fragment translocates into the
cytoplasm. The enzymatic activity of the A1 fragment
is NAD-dependent ADP-ribosylation of the stimulatory
regulator of the enzyme adenyl cyclase, causing its per-
manent activation and high levels of cyclic adenosine
monophosphate (cAMP) in the target cells. The action of
LT also results in the opening of the cystic ﬁbrosis trans-
membrane conductance regulator (CTFR) with increased
secretion of chloride and carbonate ions and of water and
in the inhibition of sodium absorption, leading to watery
cholera-like diarrhoea. Newborn and weaned piglets and
humans in developing countries are especially sensitive
to the action of LT that can also be involved in trav-
eller’s diarrhoea cases (Nataro and Kaper, 1998; Nagy and
Fekete, 1999; Kaper et al., 2004; Gyles and Fairbrother,
2010).
Two other LT enterotoxins (LT-IIA and LT-IIb) that differ
from LTp/h and CT antigenically and by their main recep-
tor speciﬁcity (GD1b for LT-IIA and GD1a for LT-IIb), but
that possess similar enzymatic activity, can be produced by
E. coli isolated from humans, bovines and water buffaloes
suffering diarrhoea (Table 1). The genes coding for LT-
IIa and LT-IIb are chromosome-located (Guth et al., 1986;
Holmes et al., 1986; Pickett et al., 1986; Fukuta et al., 1988;
Pickett et al., 1989).
All LT enterotoxins are very good immunogens and LTp
is present in vaccines against neonatal diarrhoea in piglets
(Nagy and Fekete, 1999; Radostits et al., 2007).
4.2.2. The Vero/Shiga toxins
In 1977, Konowalchuk et al. (1977) observed in vitro
that culture supernatants of some E. coli isolates produced
a profound cytotoxic effect on Vero cells. Two  distinct
Verotoxin (VTx) families have been described, VTx1 and
VTx2. VTx1 is nearly identical to the Shiga toxin of Shigella
dysenteriae serotype 1 and the term Shiga toxin (Stx) was
also proposed to design this group of cytotoxins (O’Brien
et al., 1982). In addition, three variant forms of VTx1 and
seven variant forms of VTx2 have been described, called
VTx1a, VTx1c, VTx1d and VTx2a through VTx2g, respec-
tively (Scheutz et al., 2012). VTx are produced by human,
porcine and bovine VTEC and EHEC (Table 1). Strains
producing VTx2a, VTx2c and/or VTx2d are more often asso-
ciated with the haemolytic–uremic syndrome (HUS) in
humans while VTx2e is associated with oedema disease
in swine (Mainil and Daube, 2005; Gyles and Fairbrother,
2010; Johannes and Romer, 2010; Karmali et al., 2010;
Pennington, 2010; Sandvig et al., 2010; Bolton, 2011). The
majority of VTx are encoded by phage-located genes that
can be lost or acquired by other E. coli not only in vitro,
but also in vivo (Karch et al., 1992; Toth et al., 2003;
Bielaszewska et al., 2007).
VTx are also A1B5 toxins using Gb3, or Gb4 for VTx2e,
as cell surface receptors, but their target cells in vivo are
not the enterocytes. VTx can indeed cross the human and
porcine intestinal epithelium by transcytosis through the
enterocytes, i.e. endocytosis followed by exocytosis at the
basal pole. Still, the actual mechanism of crossing is not
fully understood and may  differ between humans and
piglets since the human enterocytes do not express the Gb3
receptor (Björk et al., 1987; Philpott et al., 1997; Hurley
et al., 1999) while porcine enterocytes do express the Gb4
receptor (Waddell et al., 1996).
In humans, and also probably in piglets, VTx subse-
quently travel in the blood stream in association with
leucocytes and attach to the receptors on the endothe-
lial cells, more especially of the renal glomerulus vessels
in humans, but of vessels all over the body in pigs.
After internalization, the whole toxin begins a retrograde
transport in the endocytic vesicles to the endoplasmic
reticulum via the Golgi apparatus where the A subunit is
enzymatically cleaved. Thereafter the activated A1 frag-
ment translocates into the cytoplasm and cleaves the 28S
rRNA via N-glycosylation of a speciﬁc adenine residue.
The protein synthesis is inhibited in the endothelial cells
and the blood vessel walls are damaged. VTx eventually
provoke thrombotic microangiopathy, leading to haemol-
ysis, thrombocytopaenia and renal failure in humans (=HUS
syndrome) (Mainil and Daube, 2005; Johannes and Romer,
2010; Karmali et al., 2010; Sandvig et al., 2010; Bolton,
2011) or to extra-vasation in piglets (=oedema disease)
(Nagy and Fekete, 1999; Gyles and Fairbrother, 2010).
VTx-producing E. coli strains can also colonize the
intestines of ruminants, though VTx cause no vascular
lesion and no disease in ruminants (=healthy carriers) for
at least two reasons. At ﬁrst VTx do not cross the intestinal
epithelium though bovine crypt enterocytes express the
Gb3 receptor (Hoey et al., 2002). Indeed after endocyto-
sis the intracellular trafﬁcking localizes VTx in lysosomes
leading to abrogation of transcytosis (Hoey et al., 2003).
Moreover the Gb3 receptor is not expressed on endothelial
cells of cattle (Pruimboom-Brees et al., 2000; Hoey et al.,
2002).
VTx are good immunogens and active immunization
with a VTx2e toxoid can protect piglets against oedema
Author's personal copy
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disease (Johansen et al., 1997), though no actual vaccine
has been marketed yet.
4.3. The RTX pore-forming toxins
RTX (Repeats in ToXins) toxins are a class of cytolysins
causing eukaryotic cell death and lysis by forming a
pore within the cytoplasmic membrane. These large pro-
teins (100–200 kDa) are phylogenetically related toxins
produced by Gram-negative bacteria, characterized by
the presence of nanopeptide repeats near the carboxyl-
terminus that bind Ca2+ and are necessary for full toxic
activity, and secreted into the culture supernatant by a
type 1 secretion system (China and Goffaux, 1999). The
most representative are the leucotoxins/haemolysins of
Mannheimia haemolytica (Lkt), Actinobacillus pleuropneu-
moniae (Apx), Morganella morganiii (Mmx), and Moraxella
bovis, whose role in the pathogenesis of the infection has
been demonstrated (Oxhamre and Richter-Dahlfors, 2003;
Mainil, 2005b). But the ﬁrst described RTX toxin is the
107 kDa 1024 amino-acid long E. coli  haemolysin (Kayser,
1903) that is today one of the most studied RTX toxins.
The  haemolysin (or HlyA) is produced by several
pathogenic types of E. coli causing extra-intestinal (cystitis,
nephritis, meningitis, septicaemia in humans and animals)
and intestinal (enteritis and enterotoxaemia in piglets)
infections, more especially NTEC, ETEC, and VTEC strains,
but sometimes also by strains not belonging to any classical
pathotype (Table 1). The gene clusters encoding the HlyA
can be located on the chromosome, sometimes as part of
pathogenicity islands more especially in NTEC1 and UPEC,
or on plasmids, more especially in porcine ETEC and VTEC
strains (Table 1) (Bertschinger and Gyles, 1994; Hampson,
1994; Nataro and Levine, 1994; Ludwig and Goebel, 1997;
De Rycke et al., 1999; Dozois and Curtiss, 1999; Mainil et al.,
1999; Mainil, 2003b).
The actual role of HlyA in the pathogenesis of E. coli
is still a question of debate. Contradictory results were
obtained in early experiments, but recombinant DNA tech-
niques to produce allelic mutants provided more direct
evidence that HlyA plays some role in extra-intestinal
infections: HlyA is not sufﬁcient for virulence, but enhances
the virulence of exraintestinal pathogenic E. coli in the pres-
ence of other pathogenic traits. However the results still
depends on the experimental models and the precise role of
HlyA remains unclear. Conversely, there exists no evidence
at all that HlyA plays any role in intestinal infections (Gyles,
1994; Ludwig and Goebel, 1997; Mainil, 2003b; Oxhamre
and Richter-Dahlfors, 2003).
An Hly-related (>60% genetic homology) haemolysin
of E. coli is the enterohaemolysin (or EhxA) that is active
only on washed sheep red blood cells and is produced by
aEPEC, VTEC, and EHEC strains. Several alleles have been
described, some being associated more speciﬁcally with
VTEC strains, and others with aEPEC and EHEC strains.
The EhxA-encoding genes are located on a plasmid. But
the question of the role of EhxA in the pathogenesis of
those strains remains unresolved, although antibody can
be detected in humans infected with Ehx-positive EHEC
(Beutin et al., 1988; Gyles, 1994; Ludwig and Goebel, 1997;
Mainil and Daube, 2005; Cookson et al., 2007).
5. Discussion
Bacterial vaccines can comprise either whole cells of
bacterial strains with suspected pathogenicity or bacterial
extracts of virulence factors. Either vaccine type has got
advantages and disadvantages: the former contains all bac-
terial immunogens, but blindly include strains of unknown
virulence mechanisms; the latter targets the precise vir-
ulence mechanisms, but may  not include all pathogenic
strains and some virulence factors are no good immuno-
gens. Moreover to be recognized as an actual virulence
factor, a bacterial property must respond to the deﬁnitions
of the four molecular Koch’s postulates (Falkow, 1988).
The fourth of these postulates reads as follows: “Speciﬁc
antibodies must be produced and confer at least partial
protection”. With the huge technical development in the
molecular ﬁeld, whole genome sequencing of bacteria is
a matter of hours, without mentioning the possibility to
study whole bacterial populations (metagenomics). But,
however this progress is necessary to help us to better
know the fundamentals of the bacterial world, medical
bacteriologists still need to go back to the basics in bac-
terial pathogenicity and to in vivo reproduction of the
diseases in animal models to identify and understand
bacterial pathogens and their actual virulence factors.
Only then can we  begin to work at the vaccinology
level.
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